Search results for "OTHER"

showing 10 items of 12132 documents

1088 Minimally-invasive pelvic exenteration: a survival analysis

2021

Minimally-invasive pelvic exenteration: a survival analysis. Introduction/Background* Pelvic exenteration for recurrent and persistent gynecological malignancies is traditionally performed with open approach (OA). Nevertheless, reports on the use of minimally-invasive surgical (MIS) approach to pelvic exenteration have been published with promising results in terms of peri-operative morbidity. However, oncological safety of this approach has been poorly investigated. The aim of the present study was to assess the disease-free survival (DFS) and overall survival (OS) of patients undergoing minimally-invasive pelvic exenteration. Methodology All patients undergoing pelvic exenteration for gyn…

medicine.medical_specialtyMultivariate analysisSurgical approachPelvic exenterationbusiness.industryProportional hazards modelAdjuvant chemotherapymedicine.medical_treatmentSurgeryMedian follow-upMedicinebusinessGrading (tumors)Survival analysisMiscellaneous
researchProduct

Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospit…

2012

Invasive fungal disease (IFD) causes increasing morbidity and mortality in haematological cancer patients. Reliable cost data for treating IFD in German hospitals is not available. Objective of the study was to determine the institutional cost of treating the IFD. Data were obtained by retrospective chart review in German hospitals. Patients had either newly diagnosed or relapsed acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS). Direct medical cost was calculated from hospital provider's perspective. A total of 108 patients were enrolled at 5 tertiary care hospitals, 36 IFD patients and 72 controls. The vast majority of IFD patients (74%) were diagnosed with invasive aspergil…

medicine.medical_specialtyMyeloidbusiness.industryMyelodysplastic syndromesRetrospective cohort studyDermatologyGeneral MedicineAspergillosismedicine.diseaseIndirect costsInfectious DiseasesInvasive fungal diseasePharmacotherapymedicine.anatomical_structureInternal medicinemedicineYoung adultbusinessIntensive care medicineMycoses
researchProduct

Laser and other treatment options in the therapy of infantile capillary eyelid and periorbital hemangiomas: An overview

2010

Abstract Hemangiomas in infancy generally require a multidisciplinary approach. As a result of their natural course, usually with spontaneous involution, a “watch-and-wait” strategy often seems to be sufficient. Nevertheless, in periorbital hemangiomas not only cosmetic but also functional aspects may require an early intervention. There are many treatment options such as steroids, surgery, cryotherapy, magnesium seeds and laser. The present paper focuses on the different types of laser used in the treatment of infantile capillary eyelid and periorbital hemangiomas.

medicine.medical_specialtyNatural coursebusiness.industrymedicine.medical_treatmentTreatment optionsCryotherapyDermatologymedicine.diseaseDermatologyeye diseasesSurgerybody regionsHemangiomamedicine.anatomical_structuremedicineSurgerysense organsEyelidbusinessMedical Laser Application
researchProduct

Efficacy and Safety of Multiple Doses of Imab362 in Patients with Advanced Gastro-Esophageal Cancer: Results of a Phase Ii Study

2014

ABSTRACT Aim: IMAB362 is a monoclonal antibody specifically targeting claudin 18 isoform 2 (CLDN18.2), which is expressed on gastric cancer cells, whereas it is only present on a fraction of healthy stomach cells. This may reduce the risk of target-related side effects. Single-agent IMAB362 appears safe in patients with advanced gastro-esophageal cancer (GEC) based on data from a phase I trial. Methods: This international, multicenter, non-randomized phase IIa study (NCT01197885) investigated the efficacy and safety of repeated doses of IMAB362 (300 and 600 mg/m2) in patients with metastatic, refractory/recurrent, CLDN18.2-positive GEC (i.e. cancer of the stomach, the lower esophagus and th…

medicine.medical_specialtyNauseabusiness.industryPhases of clinical researchHematologyEsophageal cancermedicine.diseaseChemotherapy regimenGastroenterologyOncologyResponse Evaluation Criteria in Solid TumorsInternal medicineAnesthesiamedicineVomitingProgression-free survivalmedicine.symptomAdverse effectbusinessAnnals of Oncology
researchProduct

Tissue characteristics in non-culprit lesions during the acute coronary event and at ten months follow-up

2013

Introduction: It is not well established how the medication recommended in the guidelines will affect plaque compositional changes in non-culprit segments after STEMI. We hypothesized that the proportion of necrotic tissue in the non-culprit lesion in the culprit artery would decrease ten months after STEMI. Methods: In 63 consecutive STEMI patients the non-culprit segment in the culprit artery was analyzed with iMap intravascular ultrasound (IVUS) at the time of the index procedure and 10 months later. The non-culprit segment was identified as being 20mm proximal to the most stenotic culprit segment. All patients were recommended to receive the drug therapy outlined in the STEMI guidelines…

medicine.medical_specialtyNecrosisCoronary eventmedicine.diagnostic_testbusiness.industryCulpritSurgeryLesionPharmacotherapyCulprit arteryInternal medicineCulprit lesionIntravascular ultrasoundmedicineCardiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Introduction

2007

medicine.medical_specialtyNecrosisHepatologybusiness.industryRibavirinGastroenterologyMEDLINEAlpha interferonHepatitis CHepatitis Bmedicine.diseaseGastroenterologychemistry.chemical_compoundPharmacotherapychemistryChronic hepatitisInternal medicinemedicinemedicine.symptombusinessDigestive and Liver Disease
researchProduct

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

2014

Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psychotherapy or a combination of both methods. The data from literature show that those treatment methods lead to an improvement of clinical symptoms, but they exert a possible impact on cognitive functions. However the study results referring both to the role of pharmacological treatment and psychotherapy in this domain are still inconsistent. There is an increasing number of accessible data confirm…

medicine.medical_specialtyNeurologyClinical NeurologyPsychological interventionAnxietyPsychiatry and Preclinical Psychiatric Studies - Review articlemedicineHumansApathyCognitive skillPsychiatryBiological PsychiatryPsychotropic DrugsDepressionAnhedoniaCognitionAnxiety DisordersDatabases BibliographicPharmacotherapyCognitive functionsPsychotherapyPsychiatry and Mental healthNeurologyAnxietyNeurology (clinical)medicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologyJournal of Neural Transmission : Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies
researchProduct

Economic Evaluation in Neurological Physiotherapy: A Systematic Review

2021

This systematic review was carried out to compile and assess original studies that included economic evaluations of neurological physiotherapy interventions. A thorough search of PubMED, Cochrane and Embase was developed using keywords such as health economics, neurological physiotherapy and cost analysis, and studies published during the last six-year term were selected. A total of 3124 studies were analyzed, and 43 were eligible for inclusion. Among the studies analyzed, 48.8% were interventions for stroke patients, and 13.9% were focused on Parkinson’s disease. In terms of the countries involved, 46.5% of the studies included were developed in the UK, and 13.9% were from the USA. The eco…

medicine.medical_specialtyNeurologyPsychological interventionDiseaseReviewmedicallcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicine030212 general & internal medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryHealth economicsphysical therapy modalitiesNeurological PhysiotherapyCost–benefit analysisbusiness.industryGeneral Neurosciencecost-benefit analysisneurologyeconomicsEconomic evaluationCost analysisPhysical therapybusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Neuronavigation and epilepsy surgery

2010

Resective epilepsy surgery is an elective therapy indicated in focal epilepsy patients who are resistant to pharmacotherapy. Every effort should be undertaken to perform the procedures as safe and less traumatic as possible. Neuronavigation could represent a suitable tool to reduce surgical morbidity and increase surgical radicality. Here, we present a series of 41 patients who were operated on for medically intractable epilepsy using neuronavigation. Overall, complication rate was 17% with a favourable seizure outcome of 88% (Engel’s class I/II). Our data suggest that neuronavigation is a valuable surgical technique to accomplish a favourable outcome in epilepsy surgery.

medicine.medical_specialtyNeuronavigationbusiness.industryMedically intractable epilepsySeizure outcomemedicine.diseaseSurgerySurgical morbidityEpilepsyPharmacotherapyMedicineComplication rateEpilepsy surgerybusinessHealth
researchProduct

Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension.

2001

The main purpose of this study was to compare efficacy, tolerability and influence on quality of life (QOL) of nifedipine gastrointestinal therapeutic system (NI) 30-60 mg once a day vs amlodipine (AM) 5-10 mg once a day in elderly patients with mild-moderate hypertension.This was a randomized, double-blind, parallel-group, multicenter study. After a 2-week single-blind placebo run-in, patients were randomized to either NI 30 mg or AM 5 mg. Responders continued on the same dosage for 16 additional weeks, while non-responders were titrated to 60 mg NI or 10 mg AM.Blood pressure was measured by mercury sphygmomanometer and efficacy equivalence of NI and AM tested by covariance analysis. Diast…

medicine.medical_specialtyNifedipinemedicine.medical_treatmentBlood PressurePlaceboNifedipineQuality of lifeDouble-Blind MethodInternal MedicinemedicineHumansAmlodipineAgedAged 80 and overChemotherapybusiness.industryGeneral MedicineMiddle AgedCalcium Channel BlockersSurgeryNifedipine gitsBlood pressureTolerabilityTherapeutic EquivalencyAnesthesiaHypertensionQuality of LifeAmlodipineCardiology and Cardiovascular Medicinebusinessmedicine.drugBlood pressure
researchProduct